STW grant for Dömling and Meurs
The Technology Foundation STW has granted Prof. Alexander Dömling (Drug Design group) and Prof. Herman Meurs (Molecular Pharmacology group) of the Groningen Research Institute of Pharmacy and Prof. Philip Elsinga of the UMCG EUR 850,000 for their research proposal “Design, Synthesis and Validation of Potent and Isozyme Selective Arginase Inhibitors for Therapeutic Use in Asthma”. Industrial partners will invest an additional EUR 166.000,- in the project. The grant was awarded within the Open Technology programme. STW awarded seven research proposals in total.
| Last modified: | 07 August 2020 11.46 a.m. |
More news
-
03 July 2025
Erik Heeres receives RUG Impact Innovator Excellence Award
During the RUG Ventures Innovation Day, Prof. Erik Heeres of the Faculty of Science and Engineering (RUG) was awarded the Impact Innovator Excellence Award.
-
02 July 2025
€ 30 million investment for UG spin-off Portal Biotech
Portal Biotech, a pioneer in nanopore-based protein identification and sequencing technology, has raised € 30 million in Series A funding. The funding will support commercial rollout and team growth.
-
01 July 2025
‘Give seals space’
The Wadden Sea is constantly changing. Native animals need to be able to adapt in order to thrive in an environment that is shaped by the tides. By conducting research on seals in the area, PhD students Margarita Méndez-Aróstegui and Beatriz...